Humana Inc.
HUM
$265.98
$3.861.47%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.25% | 11.31% | 10.43% | 10.64% | 18.24% |
| Total Other Revenue | 14.01% | 9.98% | 10.67% | 13.21% | 10.70% |
| Total Revenue | 10.40% | 11.26% | 10.44% | 10.73% | 17.93% |
| Cost of Revenue | 11.41% | 15.52% | 13.77% | 14.94% | 22.60% |
| Gross Profit | 4.13% | -8.57% | -5.00% | -8.13% | -4.59% |
| SG&A Expenses | 13.29% | 2.50% | -1.00% | 1.14% | 0.71% |
| Depreciation & Amortization | 3.48% | 4.48% | 10.99% | 12.37% | 10.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.59% | 13.77% | 11.93% | 13.28% | 19.18% |
| Operating Income | -331.52% | -38.49% | -15.81% | -26.41% | -70.51% |
| Income Before Tax | -46.18% | -41.53% | -28.04% | -38.01% | -709.21% |
| Income Tax Expenses | -188.00% | -39.45% | -24.66% | -30.08% | -29.31% |
| Earnings from Continuing Operations | -26.48% | -42.17% | -29.08% | -40.31% | -2,900.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -900.00% | -- | -66.67% | 100.00% | -133.33% |
| Net Income | -28.10% | -42.31% | -29.20% | -40.19% | -3,506.67% |
| EBIT | -331.52% | -38.49% | -15.81% | -26.41% | -70.51% |
| EBITDA | -91.82% | -31.96% | -12.64% | -22.20% | -37.62% |
| EPS Basic | -30.23% | -40.86% | -26.77% | -38.20% | -3,599.92% |
| Normalized Basic EPS | -236.78% | -38.82% | -20.13% | -33.93% | -251.25% |
| EPS Diluted | -30.47% | -40.69% | -26.54% | -38.10% | -3,599.92% |
| Normalized Diluted EPS | -236.78% | -38.73% | -19.93% | -33.79% | -251.25% |
| Average Basic Shares Outstanding | -1.64% | -2.45% | -3.31% | -3.22% | -2.53% |
| Average Diluted Shares Outstanding | -1.64% | -2.60% | -3.55% | -3.42% | -2.53% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 12.38% |
| Payout Ratio | 0.24% | 0.70% | 0.36% | 0.82% | 0.97% |
